ACC1 |
Acetyl coenzyme-A carboxylase-1 |
AD |
Alzheimer’s disease |
AMP |
Adenosine monophosphate |
5′-AMPK |
5′-AMP-activated protein kinase |
2-AcGs |
2-acyl-glycerols |
AEA |
Arachidonoylethanolamide (anandamide) |
BMT |
Bone marrow transplantation |
2-AG |
2-arachidonoylglycerol (2-AG) |
CAGE |
Cap Analysis of Gene Expression |
CBR |
Cannabinoid receptor |
CBD |
Cannabidiol |
CB1R |
Cannabinoid receptor 1 |
CB2R |
Cannabinoid receptor 2 |
CNS |
Central nervous system |
COX-2 |
Cyclooxygenase |
CXCR4 |
Chemokine receptor type 4 |
DHA |
Docosahexaenoic acid |
DHA-EA |
Docosahexaenoyl ethanolamide |
DHG |
Docosahexanoyl-glycerol |
ECS |
Endocannabinoid system |
ECLs |
Endocannabinoid-like molecules |
ENTs |
Equilibrative nucleoside transporters |
EMA |
European Medicines Agency |
EPA |
Eicosapentaenoic acid |
EPA-EA |
Eicosapentaenoyl ethanolamide |
EPG |
Eicosapentanoyl-glycerol |
FAAH |
Fatty acid amide hydrolase |
FANTOM |
Functional ANnoTation Of the Mammalian genome |
FAS |
Fatty acid synthase |
GLUT 4 |
Glucose transporter type 4 |
GPCR |
G Protein-coupled receptor |
GTEx |
Genotype-Tissue Expression |
HD |
Huntington’s disease |
HPA |
Human Protein Atlas |
IL-2 |
Interleukin 2 |
IRS-2 |
Insulin receptor substrate 1 and 2 |
LEA |
N-linoleoyl-ethanolamine |
2-LG |
2-linoleoyl-glycerol |
LPL |
Lipoprotein lipase |
MAGL |
Monoacylglycerol lipase |
MS |
Multiple Sclerosis |
NAEs |
N-acylethanolamines |
OEA |
N-oleoyl-ethanolamine |
PEA |
N-palmitoyl-ethanolamine |
2-OG |
2-oleoyl-glycerol |
P-gp |
P-glycoprotein |
PPARγ |
Peroxisome proliferator-activated receptor gamma |
PGs |
Prostaglandins |
PGE2
|
Prostaglandin E2 |
PG-G |
Prostaglandin-glycerol esters |
PG-EA |
Prostaglandin-ethanolamides |
n-3 PUFA |
n-3 Poly- Unsaturated Fatty Acid |
SNS |
Sympathetic nervous system |
SREBPF1 |
Sterol regulatory element binding transcription factor 1 |
TAGs |
Triacylglycerols |
Δ9-THC |
Δ9-Tetrahydrocannabinol |
WAT |
White adipose tissue |